secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vivani Medical, Inc. (VANI)
CIK:        0001266806
Form:       8-K
Filed at:   2024-03-05T23:59:59+00:00
Accession:  0001753926-24-000466
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vivani Medical prices $15M registered direct offering of 3.95M shares and warrants at $3.80
--------------------------------------------------------------------------------

- Offers 3,947,368 shares of common stock and warrants to purchase same amount; gross proceeds ~$15.0M.
- Warrants exercisable at $3.80/share immediately and expire three years from issuance.
- Closing expected on or about March 5, 2024; Maxim Group is sole placement agent.
- Directors and officers subject to 90-day lock-up; company has 45-day no-issuance commitment.
- Preclinical-stage biopharma developing GLP-1 implants; proceeds for general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1266806/000175392624000466/0001753926-24-000466-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1266806/000175392624000466/g084097_8k.htm
  HTML page:      https://secwatch.observer/filing/0001753926-24-000466

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer